Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ictero Medical
AddedFeb 15, 2024
UpdatedJun 18, 2026
Ictero Medical

Ictero Medical

Inactive

Ictero Medical: Pioneering minimally-invasive cryoablation solutions for gallstone disease.

HQ
Houston, TX, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Ictero Medical is dedicated to pioneering minimally-invasive cryoablation solutions for treating gallstone disease. The company offers a unique approach that provides the benefits of traditional surgery without the associated risks. Ictero Medical's core mission is to develop innovative medical technology that addresses significant clinical needs, focusing on improving patient outcomes with less invasive procedures.

Founded through the Texas Medical Center Biodesign fellowship, Ictero Medical boasts a team of passionate engineers, scientists, clinicians, and entrepreneurs. The company has made significant strides in the medical field by developing its groundbreaking gallbladder ablation solution. This innovation has the potential to transform the treatment landscape for gallstone disease, offering a safer and more effective alternative to conventional surgical methods.

Ictero Medical - Similar Companies

Ionix Medical logo

Ionix Medical

CryoMedix logo

CryoMedix

cryomedix.com

Intact Medical logo

Intact Medical

Micro Medical Solutions logo

Micro Medical Solutions

Nectero Medical logo

Nectero Medical

necteromed.com

Medical Device Innovations logo

Medical Device Innovations

FastWave Medical logo

FastWave Medical

IC Surgical logo

IC Surgical

icsurgical.com

4C Medical Technologies logo

4C Medical Technologies

4cmed.com

Calyxo logo

Calyxo

calyxoinc.com

Corveus Medical logo

Corveus Medical

corveusmedical.com

MediCool Technologies logo

MediCool Technologies

medicooltech.com

Adagio Medical logo

Adagio Medical

Thermedical logo

Thermedical

thermedical.com

Vitaheat Medical logo

Vitaheat Medical

Ictero Medical - Quick Facts

Who are Ictero Medical's competitors?

Companies similar to Ictero Medical include Ionix Medical, CryoMedix, Intact Medical and Micro Medical Solutions.

When was Ictero Medical founded?

Ictero Medical was founded in 2018.

Where is Ictero Medical's headquarters located?

Ictero Medical's headquarters is located in Houston, TX, US.

When was Ictero Medical's last funding round?

Ictero Medical's most recent funding round was for $6M (USD) in April 2022.

How much has Ictero Medical raised to-date?

As of Apr 29, 2022, Ictero Medical has raised a total of $14.8M (USD).

Ictero Medical - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • Global
Revenue
  • Recurring
Main Product
  • Medical Devices
Tags
  • Hardware
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified